| Trial ID: | L0375 |
| Source ID: | NCT00563355
|
| Associated Drug: |
Erythropoietin
|
| Title: |
A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Disease|Kidney Diseases|Cardiovascular Diseases
|
| Interventions: |
DRUG: erythropoietin
|
| Outcome Measures: |
Primary: endothelial function and atherosclerosis, 6 month, 1 year|cardiac hypertrophy and cardiac function, 6 month, 1 year | Secondary: nutrition status, 6 month, 1 year|residual renal function, 6 month, 1 year|quality of life, 6 month, 1 year
|
| Sponsor/Collaborators: |
Sponsor: Hospital Authority, Hong Kong | Collaborators: The Hong Kong Society of Nephrology
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
66
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2001-02
|
| Completion Date: |
2003-11
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-16
|
| Locations: |
Prince of Wales Hospital, Hong Kong, China
|
| URL: |
https://clinicaltrials.gov/show/NCT00563355
|
